This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Nomad Bioscience Gmbh. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2025
Title: Steve Schulz: Innovator in Bacteriocin Research
Introduction
Steve Schulz is a notable inventor based in Halle, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of bacteriocins. With a total of 3 patents, Schulz's work focuses on innovative methods to control bacterial infections.
Latest Patents
One of Schulz's latest patents involves the use of bacteriocins for the control of salmocins. This invention relates to bacteriocins that can be derived from various sources and expressed in plants. The application of these salmocins aims to prevent or reduce infection or contamination of objects, showcasing the potential of his research in practical applications.
Career Highlights
Steve Schulz is currently associated with Nomad Bioscience GmbH, where he continues to advance his research in bacteriocin technology. His work has positioned him as a key figure in the biotechnology sector, contributing to innovative solutions for microbial control.
Collaborations
Throughout his career, Schulz has collaborated with notable colleagues such as Anatoli Giritch and Simone Hahn. These partnerships have further enriched his research and development efforts in the field.
Conclusion
Steve Schulz's innovative work in bacteriocin research highlights his commitment to advancing biotechnology. His contributions are paving the way for new methods to combat bacterial infections, making a significant impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile